Europe's hospitals running out of ICU meds for COVID-19

Image
AP London
Last Updated : Apr 02 2020 | 6:16 PM IST

Nine leading European university hospitals are warning they will run out of essential medicines needed for COVID-19 patients in intensive care in less than two weeks as they are increasingly crushed by the pandemic.

The European University Hospital Alliance said that without countries cooperating to ensure a steady supply of these drugs, doctors and nurses might no longer be able to provide adequate intensive care for people critically ill with the new coronavirus.

In a statement published this week and sent to national governments, the group said that aside from the need for protective gear and ventilators, the most urgent need now is for the drugs that are necessary for intensive care patients.

They wrote that existing stocks of muscle relaxants, sedatives and painkillers were likely to run out in two days in the hardest-hit hospitals, and in two weeks in others.

The shortage has led some hospitals to buy alternative drugs or try other doses on patients.

It is extremely worrying that overworked and often less-experienced nurses and doctors-in-training, drafted to fill the gaps, have to use products and dosages that they are not used to, the group wrote, on behalf of hospitals in Austria, Britain, France, Germany, Italy, the Netherlands, Belgium, Sweden and Spain.

The hospital group noted that some governments had reacted to the shortages by refusing to export drugs elsewhere, and warned this would prevent drugs from reaching hospitals in dire need of the medicines.

No single country in Europe has the production facilities to provide all the drugs (or protective gear or ventilators) needed, they wrote. Coordinated European action will be of vital importance.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 02 2020 | 6:16 PM IST

Next Story